Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous ropivacaine wound infusion after cesarean delivery for postoperative pain management
2017-004797-33Phase 4Completed
- Sponsor
- CHU Tivoli
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Continuous ropivacaine wound infusion with Continuous placebo wound infusion (2 arms). Primary endpoint: Total opioid use in first 48 hours. Started Apr 2018; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2017-004797-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004797-33.